CS Paper Radar

Translation of Black-Box Clinical Prediction Models into Standalone Transparent Nomograms: Temporal External Validation in Heart Transplantation

Henry Pigot, Paulo J. G. Lisboa, Sandra Ortega-Martorell, Ivan Olier, Joseph Mahon, Johan Nilsson

cs.LG stat.AP ·submitted 2026-09-07 15:17 UTC · v1
code/data

Abstract

We convert black-box clinical prediction models for tabular data into standalone nomograms that can be audited term by term. PRiSM (Partial Responses in Structured Models) takes the shape of each effect and interaction from the source model, not merely which variables mattered, and lets the outcome select and weight them. We tested this in 50,356 heart transplant recipients, with validation in a later era than training. Nomograms from all 5 source models - a public clinical risk score, logistic regression, neural networks, random forests and extreme gradient boosting - met a prespecified noninferiority criterion for discrimination before any further simplification, and generally preserved calibration and clinical net benefit. Those from the 3 machine-learning models showed no detectable difference in discrimination from de novo generalized additive and explainable boosting models, exceeded neural additive models, and carried fewer terms than the explainable boosting model. PRiSM is released as an open-source Python package.

Comment
33 pages of main text with 4 figures and 3 tables; supplemental information (supplementary methods, Figures S1-S4, Tables S1-S26) appended, 86 pages total

Closest papers

Nearest neighbours by meaning across the whole index.

CoMedBench: A Multi-Source Benchmark of Synthetic Medical Data Fidelity and Downstream Utility

cs.LG ·2026-08-13 ·Akanta Das, Farhad Al-Amin Dipto, Mrinmoy Sarkar Anto, David Rehkopf, Ayin Vala +1 more
benchmark similarity 0.63
Abstract

Access to clinical data is essential for developing reliable healthcare machine learning systems, but direct use of electronic health records is constrained by privacy regulation, institutional review, data-use agreements, and the risk of re-identification. Synthetic data promises a practical alternative: it can preserve useful statistical and clinical structure while reducing exposure of sensitive patient records. Prior studies often evaluate a single generator, one dataset, or a narrow downstream task, making it difficult to know when synthetic data can support model development and when it fails to preserve task-critical signal. We introduce CoMedBench, a reproducible benchmark that evaluates a family of generators under a common clinical-validity framework and one shared training and evaluation engine, spanning static tabular and temporal downstream tasks on established critical-care datasets. In total the benchmark spans 37 dataset-task pairs across two modalities consists of 20 static tabular and 17 temporal ICU time-series-drawn from seven public data sources: three intensive-care databases (MIMIC-III, MIMIC-IV, and eICU) together with the UCI Machine Learning Repository, the CDC BRFSS diabetes cohort (2015), NHANES (1999-2014), and the pycox survival datasets (GBSG and METABRIC). The benchmark evaluates both statistical fidelity and task utility by comparing models trained and tested across real and synthetic data. In these settings, synthetic training data preserves most of the downstream signal: on tabular tasks the reference generator CoMed-CTGAN retains a mean AUROC utility (the synthetic-to-real performance ratio) of 90.6%, rising to 97.3% for the strongest generator, CoMed-TVAE. Temporal ICU tasks are harder and more generator-sensitive: CoMed-CTGAN retains 81.6% (AUROC) and only 64.0% under the imbalance-sensitive AUPRC, whereas CoMed-TVAE still retains ~95% (AUROC).

0.04

Optimizing for the decision not the prediction: an exploration of Smooth Net Benefit as a training objective

cs.LG ·2026-09-11 ·Koen M. F. Gorgels, Lasai Barreñada, Maarten van Smeden, Ben Van Calster, Ewout W. Steyerberg +1 more
benchmark similarity 0.62
Abstract · 22 pages, 5 figures, 2 tables. Code and supplementary data available

Objective Prediction models are commonly trained using objectives such as Bernoulli negative log-likelihood (NLL), although downstream clinical decisions may depend on specific risk thresholds. We introduce Smooth Net Benefit ($σ$NB), a differentiable approximation of Net Benefit designed to align model training with threshold-specific clinical utility. Materials and Methods We evaluated $σ$NB as a training objective for logistic regression, generalized additive models (GAMs), and XGBoost with three Hessian implementations. Experiments used the Framingham cardiovascular risk dataset and 44 TabZilla datasets comprising 72 dataset-threshold combinations. Results $σ$NB training did not consistently improve Net Benefit in Framingham. Across the TabZilla benchmark, mean standardized Net Benefit for logistic regression increased from 0.5669 with NLL to 0.5765 with $σ$NB (mean difference 0.0096, 95% CI -0.0001 to 0.0193). For GAMs, mean standardized Net Benefit decreased from 0.5921 to 0.5625 (mean difference -0.0296, 95% CI -0.0721 to 0.0129). For XGBoost, NLL achieved 0.6745 compared with 0.6723--0.6735 across $σ$NB implementations. In logistic regression, $σ$NB gains were positively associated with the performance advantage of XGBoost over NLL-trained logistic regression. Discussion The effect of $σ$NB was context dependent, with modest gains concentrated in logistic regression and little benefit for more flexible model classes. This suggests that decision-focused optimization may be most useful when limited model flexibility leaves greater scope for improvement. Conclusion Our results do not support $σ$NB as a general replacement for NLL training, but support further investigation of decision-focused objectives in settings where conventional likelihood-based training may not adequately capture decision-relevant structure.

0.37

From Latent Biomarkers to Clinical Rules: Embedding-Guided Rule Mining and Attribution-Based Translation for Interpretable Tabular Learning

cs.LG ·2026-08-26 ·Majid Lotfian Delouee, Hamed Ayoobi, Sjors G. J. G. In 't Veld, Martijn C. Schut
similarity 0.62
Abstract · 12 pages, submitted to AAAI 2027

Clinical decision support tools are most useful when accurate predictions are accompanied by understandable explanations. Rule-based models provide transparency, but rules derived directly from raw clinical measurements may miss patterns arising from interactions between multiple variables. We present a four-step pipeline that mines decision rules in the latent space of an FT-Transformer and translates them back into measurable clinical features. Embedding dimensions that consistently separate patient groups are treated as latent biomarkers, rules are mined using small decision trees, and selected rules are translated using gradient-input saliency and CLS attention attribution. We evaluate the framework on six public clinical and population health datasets at four embedding dimensions. Translated rules outperformed raw-feature rules in five of six datasets, with mean AUROC gains ranging from 0.04 to 0.23. On the heart disease dataset, embedding-space rules reached 0.98 AUROC, but translation reduced this to 0.72, showing that high-performing latent rules cannot always be represented by simple raw-feature conditions. These results show that latent-space rule discovery can uncover predictive patterns while translating them into clinically measurable features that can be evaluated by clinicians.

0.32

TabBioMed: A Large-Scale Benchmark for Biomedical Tabular Learning

cs.LG ·2026-11-18 ·Pau Mateo-Bernadó, Saivenkata Nagavyjayanthi Polapragada, David Bonet, Pol Arbiol Rakuljic, Laia Mogas Pladevall +6 more
publishedbenchmarkcode/data similarity 0.62
Abstract · 87 pages, 43 figures, including appendices and the NeurIPS paper checklist

Recent advances in machine learning have accelerated biomedical prediction, but evaluation on structured biomedical data remains fragmented, especially for datasets with high dimensionality, large sample size, missingness, and class imbalance. We introduce TabBioMed, a large-scale benchmark of 94 curated public biomedical tabular datasets spanning electronic health records, drug discovery, genomics, transcriptomics, proteomics, metabolomics, single-cell omics, and systems biology. TabBioMed unifies these datasets through a standardized, dataset-aware preprocessing and evaluation framework, enabling reproducible comparison across classification, regression, and multi-target tasks. We benchmark 23 models across classical baselines, gradient-boosted trees, neural tabular architectures, and tabular foundation models. Foundation models deliver the strongest family-level predictive performance. However, their gains are regime-dependent: tree-based models and tuned multilayer perceptrons remain highly competitive, often dominating under inference-time or training-cost constraints. Overall, TabBioMed shows that biomedical tabular learning is strongly context-dependent, with optimal model choice depending on data regime, task type, and computational budget. We release TabBioMed with curated datasets and splits, preprocessing code, baselines, and results, providing a reproducible benchmark for practical model selection and future methods development in biomedical machine learning, available at https://github.com/AI-sandbox/TabBioMed.

0.44

SurvICL: a Foundation Model for in-context Survival Analysis

cs.LG stat.ML ·2026-10-15 ·Julie Alberge, Linus Bleistein, Judith Abécassis, Marine Le Morvan, Gaël Varoquaux +1 more
benchmark similarity 0.60
Abstract

Tabular foundation models (TFMs) now outperform gradient-boosted trees in classification and regression. Yet in survival analysis, which predicts when an event occurs from censored data, often on small clinical cohorts, we find that no existing TFM beats the half-century-old Cox model. We address this issue by introducing SurvICL, a TFM that predicts survival curves in-context. SurvICL is pretrained on purely synthetic datasets generated from a novel flexible proportional-odds prior that outperforms other prior types in our ablation study. Unlike most other survival models, SurvICL is trained with a plain quantile regression loss, which is possible because its synthetic pre-training data generator can provide uncensored event times. Additionally, we introduce the largest survival benchmark to date spanning 103 datasets. On the 63 datasets held out from all design decisions, SurvICL outperforms 20 tree-based, deep, and foundation-model baselines without any tuning: it wins 82.9\% of pairwise comparisons in integrated Brier score, against 71.3\% for the runner-up, the Cox model, and is the first model to rank above Cox on small datasets.

0.37

Data augmentation for the generalizability and transportability of fairness in a clinical heart failure algorithm

cs.CY stat.APstat.ME ·2026-11-11 ·I. Elizabeth Kumar, Sherri Rose
similarity 0.60
Abstract

Synthetic data augmentation has been proposed as a way to artificially supplement clinical datasets to address fairness concerns in downstream classification algorithms. This approach is closely related to upweighting or upsampling methods employed for the problem of class imbalance, which have shown mixed empirical results in practice. Synthetic data augmentation also runs the risk of overfitting to the noise present in subgroups with relatively small sample sizes, raising both generalizability and transportability concerns. We present an empirical evaluation of synthetic data augmentation for fairness in tabular data using simulation studies as well as a real-world application of in-hospital mortality classification for heart failure patients in two distinct data samples. We implement upsampling and upweighting methods as benchmarks for the implicit fairness objective of synthetic data augmentation. Our results suggest that the fairness impacts of data augmentation are sensitive to the design of the downstream algorithm as well as the deployment context and its similarity to the training data. It is crucial that studies making generalizability and transportability claims should provide empirical support for these assertions.

0.37

GeneICL: A Tabular Foundation Model for Bulk Transcriptomics

cs.LG ·2026-10-06 ·Michael Bohl, Alexander Theus, David Wissel, Valentina Boeva
similarity 0.60
Abstract

Gene expression is widely measured in biomedicine, yet clinical outcome prediction remains challenging due to high dimensionality, strong feature correlations, and limited labeled data. Large self-supervised transcriptomic foundation models often fail to outperform simple supervised baselines. Tabular foundation models offer an alternative through in-context learning, but are typically pretrained on generic synthetic data rather than transcriptomic structure. We ask whether transcriptomics-aware pretraining, rather than scale, is the missing ingredient. Towards this end, we introduce GeneICL, a 4.2M-parameter tabular foundation model combining a semi-synthetic pretraining prior built from measured bulk expression profiles with a parameter-efficient recurrent architecture. We further enable right-censored survival prediction via a training-free reduction to regression using Cox partial-likelihood residuals. We evaluate GeneICL on 80 clinical outcome-prediction tasks spanning classification, regression, and survival. Tabular foundation models consistently outperform self-supervised transcriptomic models, while GeneICL achieves the best overall rank among evaluated foundation models and tuned baselines. GeneICL does so with up to 387$\times$ fewer parameters, no gradient updates at inference, and predictions within seconds on a laptop CPU.

0.44

Explainable Transformer Models for Clinical Prediction Tasks on Structured Electronic Health Records

cs.LG ·2026-08-20 ·Jun Ni Du, Lukas Adamek, Maxim Kryukov, Flavio Dormont, Ziv Bar-Joseph +2 more
top venuebenchmark similarity 0.59
Abstract · Accepted at MLHC 2026; to appear in Proceedings of Machine Learning Research (PMLR)

Predictive models over structured electronic health records (EHRs) remain central to machine learning for healthcare, but few have jointly emphasized quantitative laboratory information and interpretability with respect to input medical events. We present BERT-LER, a BERT-style model for coded EHR timelines pretrained and fine-tuned from a de-identified EHR dataset of 75 million patients, that encodes laboratory test results as discrete tokens while retaining graded information through percentile-based binning, paired with Integrated Gradients for token-level attributions grounded in the input EHR sequence. We benchmark our approach on the public EHRShot benchmark suite and on an asthma severity progression study based on real-world data. This addresses a methodological gap in EHR foundation-style modeling by unifying laboratory value representation and explainability in a single framework, while assessing whether both predictive performance and explanations generalize beyond standard clinical prediction tasks. Across EHRShot and asthma tasks, BERT-LER achieves predictive performance that is competitive with, and on laboratory-related tasks often exceeds, publicly available benchmark models, and provides attributions that align with clinically known risk factors. Our architecture and explainability approach can be applied to many therapeutic areas and prediction tasks using language models trained on structured EHRs.

0.42